» Articles » PMID: 36604795

Transcription Factor ETS Proto-oncogene 1 Contributes to Neuropathic Pain by Regulating Histone Deacetylase 1 in Primary Afferent Neurons

Overview
Journal Mol Pain
Date 2023 Jan 6
PMID 36604795
Authors
Affiliations
Soon will be listed here.
Abstract

Nerve injury can induce aberrant changes in ion channels, enzymes, and cytokines/chemokines in the dorsal root ganglia (DRGs); these changes are due to or at least partly governed by transcription factors that contribute to the genesis of neuropathic pain. However, the involvement of transcription factors in neuropathic pain is poorly understood. In this study, we report that transcription factor (TF) ETS proto-oncogene 1 (ETS1) is required for the initiation and development of neuropathic pain. Sciatic nerve chronic constrictive injury (CCI, a clinical neuropathic pain model) increases ETS1 expression in the injured male mouse DRG. Blocking this upregulation alleviated CCI-induced mechanical allodynia and thermal hyperalgesia, with no apparent effect on locomotor function. Mimicking this upregulation results in the genesis of nociception hypersensitivity; mechanistically, nerve injury-induced ETS1 upregulation promotes the expression of histone deacetylase 1 (HDAC1, a key initiator of pain) via enhancing its binding activity to the HDAC1 promotor, leading to the elevation of spinal central sensitization, as evidenced by increased expression of p-ERK1/2 and GFAP in the dorsal spinal horn. It appears that the ETS1/HDAC1 axis in DRG may have a critical role in the development and maintenance of neuropathic pain, and ETS1 is a potential therapeutic target in neuropathic pain.

Citing Articles

Integrated bioinformatics analysis of the effects of chronic pain on patients with spinal cord injury.

Zhang J, Qi L, Sun Y, Chen S, Liu J, Chen J Front Cell Neurosci. 2025; 19:1457740.

PMID: 39974584 PMC: 11835904. DOI: 10.3389/fncel.2025.1457740.


Involvement of HDAC2-mediated kcnq2/kcnq3 genes transcription repression activated by EREG/EGFR-ERK-Runx1 signaling in bone cancer pain.

Zhang Z, Tian Y, Li S, Jing H, Cai J, Li M Cell Commun Signal. 2024; 22(1):416.

PMID: 39192337 PMC: 11350972. DOI: 10.1186/s12964-024-01797-2.


The Epigenetics of Neuropathic Pain: A Systematic Update.

Petho G, Kantas B, Horvath A, Pinter E Int J Mol Sci. 2023; 24(24).

PMID: 38138971 PMC: 10743356. DOI: 10.3390/ijms242417143.


Circ_0059662 exerts a positive role in oxygen-glucose deprivation/reoxygenation-induced SK-N-SH cell injury.

An Y, Xu D, Yuan L, Wen Y Exp Brain Res. 2023; 241(11-12):2705-2714.

PMID: 37815551 DOI: 10.1007/s00221-023-06714-6.


Spinal-Specific Super Enhancer in Neuropathic Pain.

Tao Y, Wang Q, Li X, Liu Y, Sun R, Xu H J Neurosci. 2023; 43(49):8547-8561.

PMID: 37802656 PMC: 10711714. DOI: 10.1523/JNEUROSCI.1006-23.2023.

References
1.
Conrad S, Demurger F, Moradkhani K, Pichon O, Le Caignec C, Pascal C . 11q24.2q24.3 microdeletion in two families presenting features of Jacobsen syndrome, without intellectual disability: Role of FLI1, ETS1, and SENCR long noncoding RNA. Am J Med Genet A. 2019; 179(6):993-1000. DOI: 10.1002/ajmg.a.61113. View

2.
Du S, Wu S, Feng X, Wang B, Xia S, Liang L . A nerve injury-specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression. J Clin Invest. 2022; 132(13). PMC: 9246381. DOI: 10.1172/JCI153563. View

3.
Montoya-Durango D, Liu Y, Teneng I, Kalbfleisch T, Lacy M, Steffen M . Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat Res. 2009; 665(1-2):20-8. PMC: 3418809. DOI: 10.1016/j.mrfmmm.2009.02.011. View

4.
Kumar V, Kundu S, Singh A, Singh S . Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective. Curr Neuropharmacol. 2021; 20(1):158-178. PMC: 9199543. DOI: 10.2174/1570159X19666210609160017. View

5.
Borgonetti V, Galeotti N . Combined inhibition of histone deacetylases and BET family proteins as epigenetic therapy for nerve injury-induced neuropathic pain. Pharmacol Res. 2021; 165:105431. DOI: 10.1016/j.phrs.2021.105431. View